KTTA
Pasithea Therapeutics Corp. Common Stock
stockNASDAQ
Market OpenNov 3, 2026 3:45:06 PM EST
0.51USD+39.918%(+0.15)18,303,233
Pre-marketNov 3, 2026 9:29:30 AM EST
0.376USD+2.174%(+0.008)
KTTA Financials
In Q2 FY 2026 (ended ), Pasithea Therapeutics Corp. Common Stock (KTTA) reported net income of −$5.27M, operating cash flow of −$4.71M, and assets of $51.71M.
Loading financial flows…